Donald G. Payan

Q: What Schools Are Affiliated With Donald G. Payan

Donald G. Payan is affiliated with the following schools: McMaster University, University of Washington, University of California, San Francisco

Donald G. Payan's AcademicInfluence.com Rankings

Donald G. Payan

Philosophy

#9812

World Rank

#13426

Historical Rank

Logic

#6769

World Rank

#8317

Historical Rank

philosophy Degrees

Donald G. Payan

Biology

#13504

World Rank

#17052

Historical Rank

Immunology

#934

World Rank

#958

Historical Rank

Molecular Biology

#2290

World Rank

#2324

Historical Rank

Biochemistry

#2368

World Rank

#2518

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Donald G. Payan's Degrees

PhD Biochemistry University of California, Berkeley
Doctorate Medicine Stanford University

Why Is Donald G. Payan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald G. Payan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation (2006) (475)
Specific stimulation of human T lymphocytes by substance P. (1983) (468)
Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. (1996) (460)
R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. (2010) (436)
Substance P selectively activates TNF-alpha gene expression in murine mast cells. (1993) (348)
Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. (1997) (325)
Structure and expression of a rat agrin (1991) (309)
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. (1997) (308)
Neutrophil rolling altered by inhibition of L-selectin shedding in vitro (1996) (304)
Neuropeptides and inflammation: the role of substance P. (1989) (290)
Modulation of immunity and hypersensitivity by sensory neuropeptides. (1984) (286)
Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* (1996) (269)
Substance P recognition by a subset of human T lymphocytes. (1984) (256)
Discovering patterns to extract protein-protein interactions from full texts (2004) (238)
Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. (1995) (231)
Characterization of Antisera Specific to NK1, NK2, and NK3 Neurokinin Receptors and their Utilization to Localize Receptors in the Rat Gastrointestinal Tract (1996) (213)
Detection of programmed cell death using fluorescence energy transfer. (1998) (212)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. (2007) (207)
A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores. (2003) (200)
Multiple roles for the receptor tyrosine kinase axl in tumor formation. (2005) (195)
Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. (1984) (181)
Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. (1984) (172)
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. (2008) (170)
Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. (1987) (169)
TNIK, a Novel Member of the Germinal Center Kinase Family That Activates the c-Jun N-terminal Kinase Pathway and Regulates the Cytoskeleton* (1999) (168)
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. (2005) (166)
The control of microvascular permeability and blood pressure by neutral endopeptidase (1997) (159)
Targeting Syk as a treatment for allergic and autoimmune disorders (2004) (154)
Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. (1994) (148)
Modulation of lymphocyte function by sensory neuropeptides. (1985) (141)
Neuropeptide regulation of the expression of immediate hypersensitivity. (1985) (138)
Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. (1999) (134)
Activation of the PKB/AKT pathway by ICAM-2. (2002) (133)
Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. (1984) (125)
Neuropeptide Modulation of Leukocyte Function a (1987) (123)
Immunomodulation by Tachykinin Neuropeptides a (1990) (120)
Identification of RIP3, a RIP-like kinase that activates apoptosis and NFκB (1999) (116)
p15PAF, a novel PCNA associated factor with increased expression in tumor tissues (2001) (107)
Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. (1985) (106)
Specific suppression of human T lymphocyte function by leukotriene B4. (1983) (105)
Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. (1986) (99)
Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. (1996) (99)
Effect of eicosapentaenoic acid in asthma (1988) (94)
The antagonistic effect of an inhalation anesthetic and high pressure on the phase diagram of mixed dipalmitoyl-dimyristoylphosphatidylcholine bilayers. (1975) (93)
Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. (1997) (93)
Stimulation of rat B‐lymphocyte proliferation by corticotropin‐releasing factor (1989) (90)
Direct Observation of Endocytosis of Gastrin Releasing Peptide and Its Receptor (*) (1995) (89)
Retrovirally Delivered Random Cyclic Peptide Libraries Yield Inhibitors of Interleukin-4 Signaling in Human B Cells* (2002) (89)
Endocytosis and recycling of neurokinin 1 receptors in enteric neurons (1996) (88)
Riboproteomics of the hepatitis C virus internal ribosomal entry site. (2004) (84)
Dominant effector genetics in mammalian cells (2001) (84)
Identification of Potential Tyrosine-containing Endocytic Motifs in the Carboxyl-tail and Seventh Transmembrane Domain of the Neurokinin 1 Receptor* (1997) (83)
Identification of the Syk kinase inhibitor R112 by a human mast cell screen. (2006) (82)
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid (1986) (82)
Multiple intracellular signaling pathways of the neuropeptide substance P receptor (1992) (80)
The Poxvirus p28 Virulence Factor Is an E3 Ubiquitin Ligase* (2004) (78)
Rab37 is a novel mast cell specific GTPase localized to secretory granules (2000) (76)
Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. (1989) (74)
Systematic identification of regulatory proteins critical for T-cell activation (2003) (72)
Pressure-induced elevation of phase transition temperature in dipalmitoylphosphatidylcholine bilayers. An electron spin resonance measurement of the enthalpy of phase transition. (1974) (72)
Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes (1987) (71)
Discovery and development of spleen tyrosine kinase (SYK) inhibitors. (2012) (70)
Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. (1999) (69)
Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. (1984) (67)
JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice (2009) (67)
Drug discovery in the ubiquitin regulatory pathway. (2003) (66)
Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. (2002) (66)
Molecular Cloning, Chromosomal Localization, and Expression of Murine Dipeptidyl Peptidase I* (1997) (65)
Functional Cloning of Src-like Adapter Protein-2 (SLAP-2), a Novel Inhibitor of Antigen Receptor Signaling (2001) (65)
Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. (1993) (63)
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen (2009) (62)
Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells. (1994) (62)
Substrate Modification with Lysine 63-linked Ubiquitin Chains through the UBC13-UEV1A Ubiquitin-conjugating Enzyme* (2007) (59)
Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. (1984) (56)
The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines. (1987) (55)
In Vitro Studies of Immunoregulation by Substance P and Somatostatin (1987) (54)
A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation (2005) (54)
Retroviral delivery of peptide modulators of cellular functions. (2000) (54)
Identification and Functional Characterization of a Novel Human Misshapen/Nck Interacting Kinase-related Kinase, hMINKβ* (2004) (53)
AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes (2013) (52)
Endogenous somatostatin-like peptides of rat basophilic leukemia cells. (1985) (50)
Intracellular protein scaffold-mediated display of random peptide libraries for phenotypic screens in mammalian cells. (2001) (49)
Dual Roles of Substance P: Modulator of Immune and Neuroendocrine Functions a (1987) (49)
The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. (1988) (45)
Infection of a brain abscess of Mycoplasma hominis (1981) (45)
R 428 , a Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer (2010) (44)
Isoforms of agrin are widely expressed in the developing rat and may function as protease inhibitors. (1993) (43)
Multiple signaling pathways of histamine H2 receptors. (1991) (42)
Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. (1987) (41)
Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction (2014) (40)
Multiple functional categories of proteins identified in an in vitro cellular ubiquitin affinity extract using shotgun peptide sequencing. (2003) (40)
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. (2014) (38)
A Novel Role for p21-Activated Protein Kinase 2 in T Cell Activation (2004) (38)
Identification of a nuclear-specific cyclophilin which interacts with the proteinase inhibitor eglin c. (1996) (37)
Binding of viridans group streptococci to human platelets: a quantitative analysis (1990) (36)
The JAK-STAT Pathway Is Critical in Ventilator-Induced Diaphragm Dysfunction (2014) (36)
Generation of a unique fibroblast-activating factor by human monocytes. (1984) (35)
A basophil-activating factor from human T lymphocytes. (1984) (34)
Discovering Patterns to Extract Protein-Protein Interactions from Full Biomedical Texts (2004) (34)
Measles virus-substance P receptor interactions. Possible novel mechanism of viral fusion. (1990) (34)
PathwayFinder: Paving the Way Towards Automatic Pathway Extraction (2004) (34)
The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics. (2001) (34)
Characterization of receptors using cyanine 3-labeled neuropeptides (1995) (34)
Stable, stoichiometric delivery of diverse protein functions. (2004) (33)
Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINK beta. (2004) (33)
High-throughput screening for inhibitors of the e3 ubiquitin ligase APC. (2005) (32)
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. (2011) (31)
Amyloid beta protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. (1991) (31)
Functional diversity of histamine and histamine receptors. (1992) (30)
Modulation of human lymphocyte function by C3a and C3a(70-77) (1982) (29)
A novel artificial loop scaffold for the noncovalent constraint of peptides. (2000) (28)
A Class of Small Molecules that Inhibit TNFα-Induced Survival and Death Pathways via Prevention of Interactions between TNFαRI, TRADD, and RIP1 (2007) (28)
Substance P and immunoregulation. (1987) (28)
Characterization and Use of Green Fluorescent Proteins from Renilla mulleri and Ptilosarcus guernyi for the Human Cell Display of Functional Peptides (2001) (26)
Characterization of functional histamine H1 receptors on a cultured smooth muscle cell line (1988) (26)
Potentiation of mitogen-induced human T-lymphocyte activation by retinoic acid. (1985) (26)
Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. (1986) (26)
9 – Biochemical and Cellular Characteristics of the Regulation of Human Leukocyte Function by Lipoxygenase Products of Arachidonic Acid (1984) (25)
The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases (2010) (24)
Substance P: a modulator of neuroendocrine-immune function. (1989) (24)
Phorbol ester-mediated desensitization of histamine H1 receptors on a cultured smooth muscle cell line. (1988) (24)
Optimization of regulated LTR-mediated expression. (2000) (24)
Stimulation of transcriptional regulatory activity by substance P. (1994) (23)
Immunologie Properties of Substance P (1991) (23)
The effect of pressure on the phase diagram of mixed dipalmitoyl-dimyristoylphosphatidylcholine bilayers. (1974) (22)
Purification of the 33,000‐dalton ligand binding‐protein constituent of the lymphoblast substance P receptor (1987) (21)
R-253 Disrupts Microtubule Networks in Multiple Tumor Cell Lines (2006) (21)
Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction. (2015) (21)
Distribution and abundance of neutral endopeptidase (EC 3.4.24.11) in the alimentary tract of the rat. (1993) (20)
Transient expression of the angiotensin II receptor: a rapid and functional analysis of a calcium-mobilizing seven-transmembrane domain receptor in COS-7 cells. (1989) (20)
Role of peptidergic neurons in ocular herpes simplex infection in mice (1989) (20)
Immunoaffinity purification of membrane protein constituents of the IM-9 lymphoblast receptor for substance P. (1987) (20)
Neuropeptide regulation of immediate and delayed hypersensitivity. (1988) (19)
Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation. (1989) (18)
Processing of the human IM-9 lymphoblast substance P receptor. Biosynthetic and degradation studies using a monoclonal anti-receptor antibody. (1988) (18)
Use of MEDUSA-based data analysis and capillary HPLC-ion-trap mass spectrometry to examine complex immunoaffinity extracts of RBAp48. (2002) (18)
A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1. (2007) (17)
Design and application of a versatile triple-laser cell and chromosome sorter. (1987) (16)
Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. (1986) (15)
Interleukin‐3 modulation of mouse bone marrow derived mast cell receptors for somatostatin (1987) (15)
Measles virus-substance P receptor interactions: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication (1992) (15)
Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways (2014) (14)
Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen (1988) (14)
Characterization of a monoclonal antibody against the lymphoblast substance P receptor. (1987) (14)
Immunopathogenetic roles of leukotrienes in human diseases (1984) (13)
Cellular localization and antiproliferative effect of peptides discovered from a functional screen of a retrovirally delivered random peptide library. (2003) (13)
Recognition of leukotriene B4 by a unique subset of human T-lymphocytes. (1984) (13)
A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly. (2005) (13)
Utility of peptide-protein affinity complexes in proteomics: identification of interaction partners of a tumor suppressor peptide. (2008) (12)
Interactions between the nervous and the immune systems (1991) (12)
Expression of substance P and somatostatin receptors on a T helper cell line. (1987) (12)
Tachykinin receptor cross-talk Immunological cross-reactivity between the external domains of the substance K and substance P receptors (1991) (11)
Molecular and cellular analysis of histamine H1 receptors on cultured smooth muscle cells (1989) (11)
Structural diversity of the fibroblast-activating factors generated by human blood monocytes and U937 cells. (1985) (11)
The use of 33P-labeled oligonucleotides for in situ hybridization of vertebrate embryo frozen sections. (1993) (10)
Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus. (2017) (9)
Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication (2008) (8)
Specific high-affinity binding sites for a synthetic gliadin heptapeptide on human peripheral blood lymphocytes. (1987) (8)
Neuro-endocrine interaction on lymphocytes Testosterone-induced modulation of the lymphocyte substance P receptor (1990) (8)
Janus kinase inhibition prevents cancer- and myocardial infarction-mediated diaphragm muscle weakness in mice (2016) (8)
The dependence of human T-lymphocyte migration on the 5-lipoxygenation of endogenous arachidonic acid (1981) (7)
Novel regulatory mechanisms of IgA synthesis: respective roles of neuropeptides and cells of the anti-suppressor circuit. (1987) (6)
Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling. (2015) (6)
Solubilization and characterization of the pyrilamine-binding protein from cultured smooth muscle cells. (1989) (6)
Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis (1984) (6)
Histamine effects on the 5‐HT1c receptor expressed in Xenopus oocytes (1991) (6)
Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B 4 ( leukocyte / lipoxygenase / hydroxyicosatetraenoic acid / immunosuppression / hypersensitivity ) (6)
CHAPTER 13 – EFFECTS OF EICOSAPENTAENOIC ACID ON IMMUNE RESPONSES AND INFLAMMATION IN HUMANS1 (1986) (5)
MECHANISMS REGULATING THE RESPONSIVENESS OF CELLS TO SUBSTANCE P : CELL-SURFACE DEGRADATION OF SUBSTANCE P AND NK-1 RECEPTOR ENDOCYTOSIS (1994) (5)
Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells. (1991) (5)
Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor (1992) (5)
In Vitro and in Vivo Inhibition of JAK2 Signaling by Potent and Selective JAK2 Inhibitor (2008) (5)
Computational and experimental studies on human misshapen/NIK-related kinase MINK-1. (2004) (4)
Abstract 346: Potential role for R191, potent and selective IRAK4 kinase inhibitor, in treatment of hematologic malignancies (2016) (4)
Cellular interacting proteins of functional screen-derived antiproliferative and cytotoxic peptides discovered using shotgun peptide sequencing. (2003) (4)
Discovery and development of an aurora kinase inhibitor clinical candidate using an image-based assay for measuring proliferation, apoptosis, and DNA content. (2009) (4)
Multidimensional data integration and relationship inference (2002) (4)
Noninvasive Imaging of In Vivo MuRF1 Expression during Muscle Atrophy (2014) (3)
Gas phase dimerization of neuropeptide head activator analogs useful for the noncovalent constraint of peptides. (2007) (3)
Application of cultured human mast cells (CHMC) for the design and structure-activity relationship of IgE-mediated mast cell activation inhibitors. (2015) (3)
Characterization of the lymphocyte substance P receptor (1986) (2)
Antibodies to the rat substance P receptor: production and characterization (1992) (2)
Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer (2010) (2)
Mediation of pulmonary immunity and hypersensitivity by neuropeptides. (1986) (2)
Approaches to discovering drugs that regulate E3 ubiquitin ligases. (2008) (2)
Evaluation and Management of Patients with Collagen Vascular Disease (1994) (2)
Detection of naturally expressed receptors for gastrin-releasing peptide and tachykinins using cyanine 3-labelled neuropeptides (1996) (2)
Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathy (1984) (1)
Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases (2010) (1)
Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors. (2022) (1)
PathwayFinder : Bridging the Way Towards Automatic Pathway Extraction (2003) (1)
A Novel Role for p 21-Activated Protein Kinase 2 in T Cell Activation (2004) (1)
Mutant PL / J Mice Psoriasiform Skin Inflammation in CD 18 JAK 3 Inhibition Significantly Attenuates (2009) (1)
Nucleophile Labeling of Cysteine and Serine Protease Substrates* (1996) (1)
Suppression of tumor growth and angiogenesis by novel small molecule inhibitors of the axl receptor tyrosine kinase (2008) (1)
Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication (cid:1) (2008) (0)
AMPK activation by a novel small molecule of mitochondrial regulation enhances fatty acid oxidation, ketogenesis and branched chain amino acid catabolism in vivo (2013) (0)
The Apparent Lack of Cell Cycle Dependency for Substance P Binding to Murine Lymphocytes (1992) (0)
Structure activity relationships leading to the identification of the indirect activator of AMPK, R419. (2022) (0)
Testing multiple parameters facs to detect alterations in cellular parameters. (1999) (0)
Compliance in Taking Medications (2005) (0)
Identification and Functional Characterization of a Novel Human Misshapen/Nck Interacting Kinase-related Kinase, hMINKÎ2* (2004) (0)
Abstract B060: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
Proteomics Approach for Identifying Interacting Partners of a C-Terminal Functional Peptide Derived from the Tumor Suppressor, p21 cip/waf1 (2001) (0)
Selective inhibitors of JAK2 kinase as potential therapeutic agents (2007) (0)
2,4-pyrimidinediamine compounds and of their applications. (2003) (0)
A Novel Role for p21-Activated Protein (2004) (0)
Characterization of a small molecule IRAK4 kinase inhibitor for the treatment of autoimmune and inflammatory diseases (2016) (0)
Delineation of Structural Constraints Imposed by a Dimerizer Peptide When Grafted Onto the Terminal Ends of a Test Peptide (2001) (0)
A process for the treatment of cell proliferation disorders with pyrimidindiaminverbindungen (2007) (0)
Integration de biodonnees multidimensionnelles et inference de relation (2002) (0)
Quantitative Analysist (0)
Abstract 3021: Development of small molecule direct AMPK activators for the treatment of cancer (2016) (0)
Novel small molecule inhibitors of the Axl receptor tyrosine kinaseblock tumor growth (2007) (0)
Optimization of Pyrimidine Compounds as Potent JAK1 Inhibitors and the Discovery of R507 as a Clinical Candidate. (2022) (0)
Abstract 2546: AXL targeted therapy blocks tumor progression and prevents tumor metastasis in pancreatic cancer (2011) (0)
Conditionally effective bispecific therapeutics (2018) (0)
Structural implications of a novel peptide dimerizer sequence when anchored to terminal ends of different peptide motifs (2002) (0)
Targeting autoimmunity: strategies and tactics. (2014) (0)
Interaction of Analgesic Capsaicin Analogs with Substance P Receptors (1987) (0)
Bicyclic pyrimidine compounds as potent IRAK4 inhibitors. (2022) (0)
Friday morning – Abstracts 130-225 WRM 130 Survey of Analytical Techniques Useful for Thin Film Material Evaluation in High Technology Applications (2013) (0)
46 A Class of Small Molecules that Inhibit TNFα-induced Survival and Death Pathways via Prevention of Interactions between TNFαRI, TRADD and RIP1 (2007) (0)
Multiparameter FACS test for the detection of alterations in cellular parameters (1999) (0)
Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways (2014) (0)
Targeting Myeloproliferative Diseases with JAK2 Inhibitors. (2007) (0)
R970, A Selective Activator of Nrf2, is Efficacious in a Murine Model of Multiple Sclerosis (2016) (0)
Abstract 4869: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
In vitro and in vivo characterization of small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
Evaluation and Management of Infections in Patients with Collagen Vascular Disease (1988) (0)
METHOD FOR THE TREATMENT OR PRuVENTION AUTOIMMUNE DISEASES WITH 2,4-pyrimidinediamine CONNECTIONS (2003) (0)
Substance P stimulation of cultured human smooth muscle cells (1986) (0)
Multiparameter facs test to determine from changes in cellular parameters (1999) (0)
2,4-pyrimidindiaminforbindelser and uses thereof (2003) (0)
Identification and functional characterization of a novel human Misshapen/Nck interacting kinase-related kinase, hMINKβ. Vol. 279 (2004) 54387–54397 (2005) (0)
Identification of Polo-like Kinase 1 inhibitors through phenotype-based approaches (2007) (0)
Brain Abscess by Mycoplasma hominis (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donald G. Payan?

Donald G. Payan is affiliated with the following schools:

Donald G. Payan's Academic­Influence.com Rankings

Donald G. Payan's Degrees

Why Is Donald G. Payan Influential?

Donald G. Payan's Published Works

Published Works

What Schools Are Affiliated With Donald G. Payan?

Donald G. Payan's AcademicInfluence.com Rankings